ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 115 filers reported holding ANAPTYSBIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,014,057 | -0.8% | 446,217 | +12.3% | 0.00% | 0.0% |
| Q2 2023 | $8,078,824 | +142635.4% | 397,189 | +52.7% | 0.00% | +33.3% |
| Q1 2023 | $5,660 | -43.4% | 260,113 | -19.4% | 0.00% | -50.0% |
| Q4 2022 | $10,004 | -98.6% | 322,802 | +1050.7% | 0.01% | – |
| Q3 2022 | $716,000 | +16.4% | 28,052 | -7.4% | 0.00% | – |
| Q2 2022 | $615,000 | -1.9% | 30,286 | +67.8% | 0.00% | – |
| Q4 2021 | $627,000 | -82.6% | 18,051 | -86.4% | 0.00% | -100.0% |
| Q3 2021 | $3,599,000 | +29.1% | 132,709 | +23.4% | 0.00% | 0.0% |
| Q2 2021 | $2,788,000 | +467.8% | 107,520 | +371.6% | 0.00% | – |
| Q1 2021 | $491,000 | -67.8% | 22,800 | -67.9% | 0.00% | -100.0% |
| Q4 2020 | $1,526,000 | -64.1% | 70,995 | -75.4% | 0.00% | -80.0% |
| Q3 2020 | $4,250,000 | +63.0% | 288,164 | +146.9% | 0.01% | +25.0% |
| Q2 2020 | $2,608,000 | -16.6% | 116,727 | -47.2% | 0.00% | -42.9% |
| Q1 2020 | $3,126,000 | -72.4% | 221,237 | -68.3% | 0.01% | -50.0% |
| Q4 2019 | $11,325,000 | -78.4% | 696,916 | -53.4% | 0.01% | -83.1% |
| Q3 2019 | $52,359,000 | -1.2% | 1,496,438 | +59.4% | 0.08% | +3.8% |
| Q2 2019 | $52,975,000 | +60.1% | 938,938 | +107.3% | 0.08% | +60.0% |
| Q1 2019 | $33,089,000 | +100.6% | 452,964 | +75.1% | 0.05% | +92.3% |
| Q4 2018 | $16,498,000 | -9.2% | 258,624 | +42.0% | 0.03% | +18.2% |
| Q3 2018 | $18,175,000 | -29.1% | 182,168 | -49.5% | 0.02% | -35.3% |
| Q2 2018 | $25,651,000 | -20.4% | 361,073 | +16.7% | 0.03% | -20.9% |
| Q1 2018 | $32,209,000 | +78.9% | 309,461 | +73.1% | 0.04% | +72.0% |
| Q4 2017 | $18,006,000 | +58.1% | 178,775 | -45.1% | 0.02% | +47.1% |
| Q3 2017 | $11,390,000 | +883.6% | 325,892 | +573.4% | 0.02% | +750.0% |
| Q2 2017 | $1,158,000 | -72.1% | 48,392 | -67.6% | 0.00% | -75.0% |
| Q1 2017 | $4,149,000 | – | 149,506 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |